NCT00066625 2013-02-01Oxaliplatin and Bortezomib in Treating Patients With Advanced CancerNational Cancer Institute (NCI)Phase 1 Terminated30 enrolled
NCT00086983 2013-01-10Rebeccamycin Analog and Oxaliplatin in Treating Patients With Refractory Solid TumorsNational Cancer Institute (NCI)Phase 1 Terminated15 enrolled